New implant aims to seal anal fistulas without repeat surgery

NCT ID NCT07021742

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a device called BioHealx, a bioabsorbable implant that is placed in the anal fistula to close the internal opening and allow healing. Researchers will enroll 50 adults with a single anal fistula that has failed previous treatment. The goal is to see if the device can successfully close the fistula and prevent it from coming back over the long term.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BioHealx Anal Fistula Device (bioabsorbable implant)
What this could lead to
If successful, this device could offer a reliable, minimally invasive way to close anal fistulas and reduce the need for repeat surgeries.
What could go wrong
This is a small, single-arm study (50 people) without a comparison group, so results may not apply to everyone. The device may fail to close the fistula or the fistula could come back.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FISTULA IN ANO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Geisinger

    RECRUITING

    Danville, Pennsylvania, 17822, United States

  • Hackensack University Medical Center

    RECRUITING

    Hackensack, New Jersey, 07601, United States

  • Maininle Health Lankenau

    RECRUITING

    Bryn Mawr, Pennsylvania, 19010, United States

  • Northwell Health

    RECRUITING

    Staten Island, New York, 10305, United States

  • The Colorectal Institute

    RECRUITING

    Fort Myers, Florida, 33912, United States

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.